Question 1

What are the potential side effects of bortezomib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of VTD in Waldenstrom's Macroglobulinemia clinical trial (NCT03335098). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of VTD in Waldenstrom's Macroglobulinemia clinical trial (NCT03335098). Contact the study team or your healthcare provider for specific answers.

Question 3

What tests or monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of VTD in Waldenstrom's Macroglobulinemia clinical trial (NCT03335098). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of VTD in Waldenstrom's Macroglobulinemia clinical trial (NCT03335098). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of VTD in Waldenstrom's Macroglobulinemia clinical trial (NCT03335098). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any travel required for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of VTD in Waldenstrom's Macroglobulinemia clinical trial (NCT03335098). Contact the study team or your healthcare provider for specific answers.

What this study is about